Redevelopment is the key to Westfield Retail Trust's earnings

Like its affiliate, the group must focus on redeveloping its stores to offset a subdued economic environment/

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week, Westfield Retail Trust (ASX: WRT) reported a 3.6% fall in half year profits which it blamed on "difficult" retail conditions. It will now hope to grow future earnings through its various redevelopment projects.

Like its affiliate company Westfield Group (ASX: WDC), the trust is focused on redeveloping its better performing centres as a way to strengthen its asset portfolio. Currently, the trust has three of its malls under redevelopment which are expected to cost around $332 million. According to The Australian Financial Review, these are due to deliver a 12% return and are part of a five- to seven-year redevelopment pipeline involving 13 centres between Australia and New Zealand.

The subdued economic environment has taken its toll on consumer confidence, however, slight growth in specialty sales have boosted the confidence of the trust's managing director Domenic Panaccio – although he still remains cautious of the retail outlook. Over the last 12 months, specialty sales have grown 0.9% as compared to 0.4% in the previous 12 months.

Other key results for the trust's half-year included:

  • Revenues gained 3.4% from $531.7 million in 2012 to $549.6 million
  • Confirmed its full-year dividend distribution forecast of 19.85c per share – up 5.9% from last year
  • 99.5% of the portfolio remained  leased
  • Re-leasing decreased by 6.2%

Are you interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »